Asian equity markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.15%, while the Hang Seng is up 0.32%. The Nikkei 225 is trading down by 0.27%. European & the US stock markets closed mixed in their previous trading session.
Meanwhile, Indian share markets have opened flat with the positive bias. The BSE Sensex is trading up by 27 points while the NSE Nifty is trading up by 9 points. The BSE Mid Cap index opened flat while BSE Small Cap index opened down by 0.1%.
Sectoral indices have opened the day on a mixed note with fast moving consumer goods sector and capital goods sector leading the pack of gainers. While, healthcare stocks and bank stocks are witnessing maximum selling pressure. The rupee is trading at 65.38 to the US$.
D-Mart parent Avenue Supermarts, which recently concluded its Rs 18.7-billion initial public offering (IPO), has listed its shares on bourses today. The D-Mart IPO, the biggest since PNB Housing Finance's Rs 30 billion offer in October last year, was subscribed more than 104 times earlier this month.
Divi's Lab share price plunged 18% in early trade after USFDA issued an import alert for company's Vishakhapattanam unit II. The unit contributes 60-65% to the total sales and 20-21% to US sales.
Information technology stocks are trading mixed with HCL Technologies and HCL Infosys being the most active stocks in this space. The board of HCL Technologies has approved a buyback plan aggregating to Rs 35 billion.
HCL Technologies share price opened the day up by 0.6%.
Moving on to the news from stocks in pharma sector. According to a leading financial daily, United States Food & Drug Administration (USFDA) has granted tentative approval to Glenmark Pharmaceuticals Inc., USA (Glenmark) for Fingolimod Capsules, 0.5 Mg.
Glenmark Pharma share price & Sun Pharma share price opened the day down by 0.3% & 1.6% respectively.
Read the complete Indian stock market update. For the terms of use, go here.
No comments:
Post a Comment